


Iconovo recruits Gary Pitcairn (PhD) as Senior Scientific Advisor
Iconovo AB announce today that Gary Pitcairn will start working for the company in the role as Senior Scientific Advisor. Gary is a recognised expert…

Iconovos vd: ”Vi siktar på en affär för ICOpre under 2024”
Iconovos vd: ”Vi siktar på en affär för ICOpre under 2024”
Året 2023 påbörjades resan för Iconovo mot att bli ett lönsamt bolag. Ett ökat…

Iconovo to present at Redeye Life Science Day November 23
Johan Wäborg, CEO, will present Iconovo at Redeye Life Science Day. Learn more about why you should invest in Iconovo and get excited by our vision to…

Busy days for Iconovo at BIO-Europe
Iconovo had three hectic days at BIO-Europe, with a large number of meetings with potential partners. The company especially highlighted their latest innovation,…

Iconovo and Arcede Pharma take the next step in the development of a new treatment for COPD
Iconovo AB (publ), which develops complete inhalation products for a global market, and Arcede Pharma, which develops inhalation treatments for COPD and…

Iconovo’s partner Monash University has completed enrollment in a Phase I clinical trial of inhaled oxytocin in ICOone
Iconovo announces that the clinical phase I study of oxytocin in the company's inhaler ICOone that was initiated earlier this year in Melbourne, Australia,…

Iconovo initiates feasibility study with Affilogic for development of inhalable Nanofitin®-based biotherapies
Iconovo initiates feasibility study with Affilogic for development of inhalable Nanofitin®-based biotherapies
Iconovo has entered into a feasibility…

Iconovo Accelerator Program
On June 1st, 2023 Iconovo launched its Iconovo Accelerator to facilitate the opportunities for the company’s customers to obtain EU funding for the development…



Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se
CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se